DnB Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.5M | Buy |
1,119,330
+127,844
| +13% | +$7.03M | 0.26% | 63 |
|
|
2025
Q1 | $70.1M | Sell |
991,486
-1,684
| -0.2% | -$119K | 0.32% | 59 |
|
|
2024
Q4 | $65.3M | Sell |
993,170
-81,458
| -8% | -$5.35M | 0.28% | 57 |
|
|
2024
Q3 | $75.5M | Buy |
1,074,628
+53,574
| +5% | +$3.77M | 0.34% | 51 |
|
|
2024
Q2 | $84.1M | Buy |
1,021,054
+153,867
| +18% | +$12.7M | 0.4% | 44 |
|
|
2024
Q1 | $75.7M | Buy |
867,187
+121,672
| +16% | +$10.6M | 0.39% | 45 |
|
|
2023
Q4 | $71.9M | Sell |
745,515
-111,156
| -13% | -$10.7M | 0.37% | 50 |
|
|
2023
Q3 | $75.8M | Buy |
856,671
+168,106
| +24% | +$14.9M | 0.45% | 41 |
|
|
2023
Q2 | $59.7M | Buy |
688,565
+70,318
| +11% | +$6.1M | 0.34% | 60 |
|
|
2023
Q1 | $60.1M | Buy |
618,247
+146,276
| +31% | +$14.2M | 0.38% | 55 |
|
|
2022
Q4 | $48.8M | Buy |
471,971
+351,136
| +291% | +$36.3M | 0.34% | 65 |
|
|
2022
Q3 | $10.2M | Sell |
120,835
-50,351
| -29% | -$4.27M | 0.08% | 205 |
|
|
2022
Q2 | $14.2M | Sell |
171,186
-3,050
| -2% | -$253K | 0.1% | 176 |
|
|
2022
Q1 | $13.4M | Buy |
174,236
+5,744
| +3% | +$443K | 0.08% | 199 |
|
|
2021
Q4 | $14.9M | Buy |
168,492
+22,246
| +15% | +$1.97M | 0.09% | 191 |
|
|
2021
Q3 | $11.3M | Buy |
146,246
+21,898
| +18% | +$1.69M | 0.07% | 210 |
|
|
2021
Q2 | $10.4M | Buy |
124,348
+56,201
| +82% | +$4.69M | 0.07% | 219 |
|
|
2021
Q1 | $5.15M | Buy |
68,147
+9,700
| +17% | +$732K | 0.04% | 315 |
|
|
2020
Q4 | $5.13M | Buy |
58,447
+25,887
| +80% | +$2.27M | 0.04% | 261 |
|
|
2020
Q3 | $2.48M | Sell |
32,560
-72,807
| -69% | -$5.54M | 0.03% | 365 |
|
|
2020
Q2 | $13M | Buy |
105,367
+14,576
| +16% | +$1.8M | 0.15% | 115 |
|
|
2020
Q1 | $7.67M | Sell |
90,791
-3,032
| -3% | -$256K | 0.11% | 139 |
|
|
2019
Q4 | $7.93M | Buy |
93,823
+75,480
| +411% | +$6.38M | 0.08% | 187 |
|
|
2019
Q3 | $1.24M | Buy |
18,343
+1,510
| +9% | +$102K | 0.01% | 515 |
|
|
2019
Q2 | $1.44M | Sell |
16,833
-1,556
| -8% | -$133K | 0.02% | 477 |
|
|
2019
Q1 | $1.63M | Sell |
18,389
-2,080
| -10% | -$185K | 0.02% | 454 |
|
|
2018
Q4 | $1.74M | Sell |
20,469
-1,331
| -6% | -$113K | 0.02% | 418 |
|
|
2018
Q3 | $2.11M | Buy |
21,800
+1,000
| +5% | +$97K | 0.02% | 391 |
|
|
2018
Q2 | $1.96M | Buy |
20,800
+800
| +4% | +$75.4K | 0.02% | 394 |
|
|
2018
Q1 | $1.62M | Buy |
20,000
+1,700
| +9% | +$138K | 0.02% | 421 |
|
|
2017
Q4 | $1.63M | Hold |
18,300
| – | – | 0.02% | 410 |
|
|
2017
Q3 | $1.7M | Hold |
18,300
| – | – | 0.02% | 380 |
|
|
2017
Q2 | $1.66M | Sell |
18,300
-700
| -4% | -$63.6K | 0.02% | 368 |
|
|
2017
Q1 | $1.67M | Buy |
19,000
+2,800
| +17% | +$246K | 0.03% | 370 |
|
|
2016
Q4 | $1.34M | Buy |
16,200
+3,100
| +24% | +$257K | 0.02% | 363 |
|
|
2016
Q3 | $1.21M | Buy |
13,100
+300
| +2% | +$27.8K | 0.02% | 366 |
|
|
2016
Q2 | $996K | Buy |
12,800
+300
| +2% | +$23.3K | 0.02% | 380 |
|
|
2016
Q1 | $1.03M | Buy |
+12,500
| New | +$1.03M | 0.02% | 384 |
|